EUVIMEDEUVIMED entdecken
Crossref

Visceral Leishmaniasis Prevalence Forecast for 2040: A Global Overview of 99 Endemic Regions and Countries Using Illness-Death Modeling

Abedin Saghafipour, Meysam Olfatifar, Ehsan Vesali-Monfared, Mahsa Sarvi, Milad Badri, Mahdi Fakhar

Journal of Research in Health Sciences · 2026

DOI: 10.34172/jrhs.11503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Research in Health Sciences, 2026. Verfasst von Abedin Saghafipour und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Visceral leishmaniasis (VL) is a fatal parasitic disease endemic to tropical regions and associated with severe complications and high mortality. Persistent challenges such as delayed diagnosis and limited treatment options highlight the urgent need for robust predictive epidemiological models. Study Design: This study was a secondary analysis conducted using cross-sectional data.

Methods

Sex-specific VL epidemiological data from 1990 to 2021 were obtained from the Global Burden of Disease (GBD) database and analyzed globally and across 98 endemic countries and regions. An enhanced illness-death model (IDM), incorporating remission, was applied to estimate the age-standardized prevalence rate (ASPR) of VL by 2040.

Results

Globally, the global ASPR of VL decreased by 94.68% between 1990 and 2021. It is projected to decrease by an additional 72.55% by 2040, declining from 0.108 in 2021 to 0.030 (95% CI: 0.020, 0.043) per 100,000 population. In 2040, ASPR is expected to remain higher in males than in females (0.041 vs. 0.019). Tropical Latin America is projected to have the highest regional ASPR at 0.583 (95% CI: 0.565, 0.602). Western Sub-Saharan Africa is the only region expected to experience an increase, rising by 417.12%. Of 83 nations, 27 are expected to exhibit increasing trends, with Djibouti demonstrating the highest projected ASPR at 20.32 (95% CI: 5.25, 78.67), a 2050.59% increase from 2021 to 2040.

Conclusion

Despite global declines in VL prevalence, significant increases are expected in Western Sub-Saharan Africa and countries such as Djibouti, highlighting the need for targeted interventions. Strengthening healthcare systems, improving vector control, and addressing sex-specific risks are crucial to maintain global progress.

Zitieren

APA

Saghafipour, A., Olfatifar, M., Vesali-Monfared, E., Sarvi, M., Badri, M., & Fakhar, M. (2026). Visceral Leishmaniasis Prevalence Forecast for 2040: A Global Overview of 99 Endemic Regions and Countries Using Illness-Death Modeling. Journal of Research in Health Sciences. https://doi.org/10.34172/jrhs.11503

Vancouver

Saghafipour A, Olfatifar M, Vesali-Monfared E, Sarvi M, Badri M, Fakhar M. Visceral Leishmaniasis Prevalence Forecast for 2040: A Global Overview of 99 Endemic Regions and Countries Using Illness-Death Modeling. Journal of Research in Health Sciences. 2026. doi:10.34172/jrhs.11503

BibTeX
@article{Saghafipour2026,
  author = {Saghafipour, Abedin and Olfatifar, Meysam and Vesali-Monfared, Ehsan and Sarvi, Mahsa and Badri, Milad and Fakhar, Mahdi},
  title = {Visceral Leishmaniasis Prevalence Forecast for 2040: A Global Overview of 99 Endemic Regions and Countries Using Illness-Death Modeling},
  journal = {Journal of Research in Health Sciences},
  year = {2026},
  doi = {10.34172/jrhs.11503}
}
Kostenlos starten →